Galecto Biotech Accelerates Financing and Secures SEK 40 Million – Investors Support Expansion of Project Portfolio in Galectin Modulator Space

Copenhagen, October 30, 2013

Galecto Biotech AB today announced that the current investor syndicate has provided SEK 40 million to accelerate product development.

Read more